Metoject (methotrexate autopen) / Medac, Eisai  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Metoject (methotrexate autopen) / Medac
NCT01871961: Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient

Completed
1
105
US
Methotrexate (Metoject® prefilled pen)
medac GmbH, PPD
Rheumatoid Arthritis (RA)
02/13
05/13
NCT02097173: Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen

Completed
1
35
US
Methotrexate
medac GmbH, PPD
Psoriasis
10/13
 

Download Options